Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae
The hospital has taken a huge step by offering “Titli-palliative care services at home” to provide curative, restorative, and life-prolonging treatment to seriously ill children
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
Subscribe To Our Newsletter & Stay Updated
